IHS Chemical Week

Regions :: Western Europe

Green Biologics closes £15.4-million financing round, to fund US renewable chemical project

3:14 AM MST | December 3, 2013 | Francinia Protti-Alvarez

Green Biologics (Abingdon, UK), has closed a £15.4-million ($25.2 million) series B financing round led by venture capital firm Sofinnova Partners (Paris) and Swire Group (London), Green Biologics announced. The funding will be used by Green Biologics to finance the eventual launch of its first commercial production facility in the United States, due to take place in 2016. Follow-on investments were also made by companies including Capricorn Venture Partners (Leuven, Belgium), Oxford Capital Partners (Oxford, UK), and Morningside Ventures (Hong Kong). Green...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa